Calumet Specialty Company Insiders

CLMT Stock  USD 22.40  0.24  1.08%   
Calumet Specialty's insiders are aggressively selling. The current insiders' sentiment regarding investing in Calumet Specialty Products stock implies that vertually all insiders are panicking. Calumet Specialty employs about 1.6 K people. The company is managed by 12 executives with a total tenure of roughly 16 years, averaging almost 1.0 years of service per executive, having 131.67 employees per reported executive.
Bruce Fleming  President
Executive Vice President - Strategy and Growth of Calumet GP, LLC

Calumet Specialty's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-11-12Jennifer StrauminsDisposed 100000 @ 20.59View
2024-05-15Gregory J MoricalDisposed 11111 @ 15.04View
2024-01-18Stephen P MawerDisposed 15037 @ 17.87View
Monitoring Calumet Specialty's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Calumet Specialty Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Calumet Specialty's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Calumet Specialty's future performance. Based on our forecasts, it is anticipated that Calumet will maintain a workforce of slightly above 1580 employees by December 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Calumet Specialty Management Team Effectiveness

The company has return on total asset (ROA) of 0.0167 % which means that it generated a profit of $0.0167 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.7222) %, meaning that it created substantial loss on money invested by shareholders. Calumet Specialty's management efficiency ratios could be used to measure how well Calumet Specialty manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Calumet Specialty's Return On Tangible Assets are comparatively stable compared to the past year. Return On Capital Employed is likely to gain to 0.17 in 2024, despite the fact that Return On Equity is likely to grow to (0.09). At this time, Calumet Specialty's Total Current Liabilities is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 79.1 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 1.8 B in 2024.
Common Stock Shares Outstanding is likely to drop to about 52.4 M in 2024. Net Loss is likely to gain to about (141.2 M) in 2024

Calumet Specialty Workforce Comparison

Calumet Specialty Products is number one stock in number of employees category among its peers. The total workforce of Energy industry is currently estimated at about 3,612. Calumet Specialty totals roughly 1,580 in number of employees claiming about 44% of equities under Energy industry.

Calumet Specialty Profit Margins

The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.04.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.110.108
Fairly Up
Pretty Stable

Calumet Specialty Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Calumet Specialty insiders, such as employees or executives, is commonly permitted as long as it does not rely on Calumet Specialty's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Calumet Specialty insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
8.5
17
2
 55,011 
 200,000 
2024-06-01
1.4286
10
7
 286,689 
 437,978 
2024-03-01
1.1429
16
14
 202,088 
 281,406 
2023-12-01
9.3333
28
3
 119,551 
 11,639 
2023-09-01
7.5
15
2
 327,486 
 14,260 
2023-06-01
3.25
13
4
 118,056 
 148,408 
2023-03-01
3.0909
34
11
 705,990 
 581,436 
2022-09-01
19.0
19
1
 35,347 
 2,428 
2022-06-01
1.1667
7
6
 52,055 
 112,591 
2022-03-01
3.125
25
8
 647,503 
 79,414 
2021-03-01
2.5
50
20
 785,556 
 397,183 
2020-12-01
4.75
19
4
 202,880 
 7,222 
2020-09-01
3.0
12
4
 73,818 
 374,641 
2020-06-01
14.0
14
1
 166,355 
 50,000 
2020-03-01
1.925
77
40
 1,180,722 
 665,514 
2019-03-01
1.0
42
42
 446,866 
 285,380 
2018-12-01
3.5556
32
9
 334,507 
 42,609 
2018-06-01
0.875
21
24
 139,554 
 164,072 
2018-03-01
2.6154
34
13
 432,886 
 34,356 
2017-12-01
3.2
16
5
 114,248 
 99,691 
2017-03-01
1.3111
59
45
 1,185,811 
 411,148 
2016-09-01
8.0
16
2
 52,585 
 153.00 
2016-06-01
1.6122
79
49
 778,108 
 338,069 
2016-03-01
22.5
45
2
 44,160 
 20,526 
2015-09-01
13.6667
41
3
 6,409 
 199.00 
2015-03-01
1.5588
53
34
 113,120 
 66,959 
2014-12-01
22.0
44
2
 15,436 
 16,200 
2014-09-01
6.0
54
9
 252,716 
 967,246 
2014-03-01
1.913
88
46
 34,558 
 266,116 
2013-12-01
1.3784
102
74
 89,519 
 70,304 
2013-09-01
1.746
110
63
 20,870 
 12,040 
2013-06-01
2.6
78
30
 8,497 
 3,789 
2013-03-01
1.9231
100
52
 151,261 
 63,800 
2012-12-01
1.5172
132
87
 80,817 
 61,681 
2012-09-01
1.8615
121
65
 18,191 
 10,897 
2012-06-01
2.625
105
40
 1,300,423 
 5,124,917 
2012-03-01
1.9219
123
64
 262,866 
 86,435 
2011-12-01
1.7353
118
68
 128,910 
 27,875 
2011-09-01
2.1961
112
51
 89,672 
 7,570 
2011-06-01
3.0357
85
28
 11,376 
 4,858 
2011-03-01
2.2419
139
62
 39,382,019 
 18,705,606 
2010-12-01
1.9787
93
47
 36,434 
 15,612 
2009-12-01
6.7778
61
9
 45,310 
 7,853 
2009-09-01
12.0
24
2
 4,996 
 6,000 
2009-03-01
11.5
23
2
 1,224,434 
 1,200,000 
2008-06-01
119.8
599
5
 622,100 
 1,437,650 
2008-03-01
1.0
1
1
 1,500 
 3,000 
2007-12-01
1.0
14
14
 11,072 
 4,018 
2007-06-01
0.2
1
5
 500.00 
 1,935,787 
2007-03-01
9.0
9
1
 101,175 
 2,250 
2006-12-01
2.1667
13
6
 9,420 
 1,824 
2006-03-01
13.0
39
3
 47,433,420 
 0.00 

Calumet Specialty Notable Stakeholders

A Calumet Specialty stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Calumet Specialty often face trade-offs trying to please all of them. Calumet Specialty's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Calumet Specialty's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Louis BorgmannCEO PresidentProfile
Bruce FlemingExecutive Vice President - Strategy and Growth of Calumet GP, LLCProfile
David LuninExecutive CFOProfile
Stephen MawerIndependent Director of Calumet GP, LLCProfile
John KompaDirector RelationsProfile
Gregory MoricalGeneral VPProfile
Chris HodgesAlpha IRProfile
Marc LawnLLC GPProfile
Vincent DonargoChief OfficerProfile
Brad McMurrayDirector RelationsProfile
Scott ObermeierLLC GPProfile
Ryan WillmanLLC GPProfile

About Calumet Specialty Management Performance

The success or failure of an entity such as Calumet Specialty often depends on how effective the management is. Calumet Specialty management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Calumet management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Calumet management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.02  0.02 
Return On Capital Employed 0.16  0.17 
Return On Assets 0.02  0.02 
Return On Equity(0.10)(0.09)
Please note, the imprecision that can be found in Calumet Specialty's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Calumet Specialty Products. Check Calumet Specialty's Beneish M Score to see the likelihood of Calumet Specialty's management manipulating its earnings.

Calumet Specialty Workforce Analysis

Traditionally, organizations such as Calumet Specialty use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Calumet Specialty within its industry.

Calumet Specialty Manpower Efficiency

Return on Calumet Specialty Manpower

Revenue Per Employee2.6M
Revenue Per Executive348.4M
Net Income Per Employee29.8K
Net Income Per Executive3.9M

Additional Tools for Calumet Stock Analysis

When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.